Y. Fukuyama

发表

The efficacy and safety of degarelix, a GnRH antagonist: a 12-month, multicentre, randomized, maintenance dose-finding phase II study in Japanese patients with prostate cancer.

Y. Ohashi, H. Akaza, S. Naito, 2012, Japanese journal of clinical oncology.

The efficacy and safety of degarelix, a GnRH antagonist: a 12-month, multicentre, randomized, maintenance dose-finding phase II study in Japanese patients with prostate cancer.

Y. Ohashi, H. Akaza, S. Naito, 2012, Japanese Journal of Clinical Oncology.